SKI Market

A+| A| A-|

Indian Indices

Sensex

73,147.32 -172.23
( -0.23%)

Global Indices

Nasdaq

46,525.67 -61.07
(-0.13%)

Dow Jones

6,603.69 7.37
(0.11%)

Hang Seng

53,162.49 699.22
(1.33%)

Nikkei 225

10,436.29 71.50
(0.69%)

Forex

USD-INR

93.02 -0.15
(-0.16%)

EUR-INR

107.32 -0.65
(-0.60%)

GBP-INR

123.03 -0.78
(-0.63%)

JPY-INR

0.58 0.00
(-0.67%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Stellant Securities (India) Ltd

Industry : Finance & Investments

BSE Code

ISIN Demat

Book Value()

526071

INE395F01023

89.0849179

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

9.53

252.52

EPS(TTM)

Face Value()

Div & Yield %

71.54

Back

Valiant Laboratories reports consolidated net loss of Rs 7.06 crore in the December 2025 quarter

Feb 11,2026

Net loss of Valiant Laboratories reported to Rs 7.06 crore in the quarter ended December 2025 as against net profit of Rs 2.35 crore during the previous quarter ended December 2024. Sales rose 48.91% to Rs 52.46 crore in the quarter ended December 2025 as against Rs 35.23 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	52.46	35.23	49
OPM %	-1.70	1.76	-
PBDT	-0.94	2.14	PL
PBT	-2.99	1.62	PL
NP	-7.06	2.35	PL

73,147.32 -172.23 ( -0.23%)

46,525.67 -61.07 (-0.13%)

6,603.69 7.37 (0.11%)

53,162.49 699.22 (1.33%)

10,436.29 71.50 (0.69%)

93.02 -0.15 (-0.16%)

107.32 -0.65 (-0.60%)

123.03 -0.78 (-0.63%)

0.58 0.00 (-0.67%)